- Email: [email protected]
DESMI expands in South Korea
NEWS
Ebara revises down 2009 outlook
J
apan’s Ebara Corp is expecting to report an operating loss of ¥5.0 billion on net sales of ¥530.0 billion for the year ending 31 March 2009. This compares with the previous outlook, issued in November 2008, of net income of ¥4.0 billion and sales of ¥550.0 million for fiscal 2009. Fluid Machinery & Systems (FMS) should see a ¥5 billion decline in net sales, due to large foreign currency rate fluctuations. Within FMS’s operating income, a ¥2.5 billion foreign exchange loss will be offset by a ¥2.5 billion increase in income due to cost reductions in Ebara’s custom pump business and the compressor and fan business. FMS’s operating income is forecast to remain at ¥11.5 billion. Ebara expects cost reductions of more than ¥8 billion in the year ending 31 March 2010. Within Custom Pumps, the Japanese company plans to implement measures to reduce risk accompanying the relocation of production facilities, stengthen overseas procurement functions to cope with foreign exchange fluctuations, and expand after sales service, mainly in the Middle East. Within Standard Pumps, Ebara should see an expansion in revenues from the after sales market and the facilities renovation market, while upgrading and strengthening supply networks to overseas markets. For further information, visit www.ebara.co.jp
DESMI expands in South Korea
D
anish marine pump manufacturer DESMI A/S is setting up an office in South Korea, in an effort to increase DESMI’s market share in one of the most important ship-building countries in the world. “By setting up our own office we signal that we will intensify our efforts on the Korean market,” said Henrik Mørkholt, sales director at DESMI A/S. Bum-Joo Lee has been appointed area sales manager and will head the new office in South Korea. “As long as we have international trade, there will always be a need for shipping. We have a minor market share in Korea, but by 16
Pump Industry Analyst
setting up an office and employing the right and enterprising people, we will make a difference. It will also ensure better communication between us and our customers, and it is important that we strengthen our network in this period when the financial crisis prevails worldwide,” added Mørkholt. For further information, visit www.desmi.com
Flowserve, Al-Rushaid open pump manufacturing facility in Saudi Arabia
F
lowserve Corp and Al-Rushaid Group have officially opened the largest pump manufacturing, repair and testing facility in the Middle East. The 11 500 sq m facility, based in Dhahran, Saudi Arabia, employs more than 100 people and is designed to support customers in the oil and gas, petrochemical, power, water, desalination, chemical and other industries. “We are very pleased to work with Flowserve to open this facility, which is designed to support major customers within Saudi Arabia and the surrounding Arabian Gulf Countries,” said Sheikh Abdullah Al-Rushaid, chairman, Al-Rushaid Group. “Together with Flowserve, we will help customers optimize plant uptime and develop ways to control their operating, maintenance and related costs.” “This state-of-the-art, robust facility helps us deliver outstanding service to our Middle East customers – its scope, size and capabilities are unmatched in the region,” said Lewis Kling, Flowserve president and CEO. “Flowserve is proud to partner with Al-Rushaid Group to bring technology and innovation to our customers in the critically important Arabian Gulf Region.” The facility is capable of certified testing to both API and international standards, for both horizontal and vertical pumps. Future expansion plans include the Middle East’s first hydraulics training centre, which will feature state-of-the-art classrooms, along with static and dynamic laboratories. For further information, visit www.flowserve.com and www.al-rushaid.com
Editorial Office: Elsevier Limited, The Boulevard, Langford Lane, Kidlington, Oxford OX5 1GB, United Kingdom Tel: +44 (0)1865 843695 Fax: +44 (0)1865 843933 Email: [email protected] Web: www.pumpindustryanalyst.com Editor: Roisin Reidy Production Editor: Lin Lucas Subscription Information An annual subscription to Pump Industry Analyst includes 12 printed issues and online access for up to 5 users. Prices: 1112 for all European countries & Iran US$1247 for all countries except Europe and Japan ¥147 800 for Japan (Prices valid until 31 December 2009) To subscribe send payment to the address above. Tel: +44 (0)1865 843687/Fax: +44 (0)1865 834971/ Email: [email protected], or via www.pumpindustryanalyst.com. Subscriptions run for 12 months, from the date payment is received. Periodicals postage is paid at Rahway, NJ 07065, USA. Postmaster send all USA address corrections to: Pump Industry Analyst, 365 Blair Road, Avenel, NJ 07001, USA Permissions may be sought directly from Elsevier Rights & Permissions Department, PO Box 800, Oxford OX5 1DX, UK; phone: (+44) 1865 843830, fax: (+44) 1865 853333, email: [email protected]. You may also contact Rights & Permissions directly through Elsevier’s home page (http://www. elsevier.com), selecting first ‘Customer Support’, then ‘General Information’, then Permissions Query Form’. In the USA, users may clear permissions and make payments through the Copyright Clearance Center, Inc., 222 Rosewood Drive, Danvers, MA 01923, USA; phone: (978) 7508400, fax: (978) 7504744, and in the UK through the Copyright Licensing Agency Rapid Clearance Service (CLARCS), 90 Tottenham Court Road, London W1P 0LP, UK; phone: (+44) 207 436 5931; fax: (+44) 207 436 3986. Other countries may have a local reprographic rights agency for payments. Derivative Works Subscribers may reproduce tables of contents or prepare lists of articles including abstracts for internal circulation within their institutions. Permission of the publisher is required for resale or distribution outside the institution. Permission of the publisher is required for all other derivative works, including compilations and translations. Electronic Storage or Usage Permission of the publisher is required to store or use electronically any material contained in this journal, including any article or part of an article. Contact the publisher at the address indicated. Except as outlined above, no part of this publication may be reproduced, stored in a retrieval system or transmitted in any form or by any means, electronic, mechanical, photocopying, recording or otherwise, without prior written permission of the publisher. Address permissions requests to: Elsevier Rights & Permissions Department, at the mail, fax and email addresses noted above. Notice No responsibility is assumed by the Publisher for any injury and/or damage to persons or property as a matter of products liability, negligence or otherwise, or from any use or operation of any methods, products, instructions or ideas contained in the material herein. Because of rapid advances in the medical sciences, in particular, independent verification of diagnoses and drug dosages should be made. Although all advertising material is expected to conform to ethical (medical) standards, inclusion in this publication does not constitute a guarantee or endorsement of the quality or value of such product or of the claims made of it by its manufacturer.
Printed by Mayfield Press (Oxford) LImited 02167
March 2009
Ebara revises down 2009 outlook
J
apan’s Ebara Corp is expecting to report an operating loss of ¥5.0 billion on net sales of ¥530.0 billion for the year ending 31 March 2009. This compares with the previous outlook, issued in November 2008, of net income of ¥4.0 billion and sales of ¥550.0 million for fiscal 2009. Fluid Machinery & Systems (FMS) should see a ¥5 billion decline in net sales, due to large foreign currency rate fluctuations. Within FMS’s operating income, a ¥2.5 billion foreign exchange loss will be offset by a ¥2.5 billion increase in income due to cost reductions in Ebara’s custom pump business and the compressor and fan business. FMS’s operating income is forecast to remain at ¥11.5 billion. Ebara expects cost reductions of more than ¥8 billion in the year ending 31 March 2010. Within Custom Pumps, the Japanese company plans to implement measures to reduce risk accompanying the relocation of production facilities, stengthen overseas procurement functions to cope with foreign exchange fluctuations, and expand after sales service, mainly in the Middle East. Within Standard Pumps, Ebara should see an expansion in revenues from the after sales market and the facilities renovation market, while upgrading and strengthening supply networks to overseas markets. For further information, visit www.ebara.co.jp
DESMI expands in South Korea
D
anish marine pump manufacturer DESMI A/S is setting up an office in South Korea, in an effort to increase DESMI’s market share in one of the most important ship-building countries in the world. “By setting up our own office we signal that we will intensify our efforts on the Korean market,” said Henrik Mørkholt, sales director at DESMI A/S. Bum-Joo Lee has been appointed area sales manager and will head the new office in South Korea. “As long as we have international trade, there will always be a need for shipping. We have a minor market share in Korea, but by 16
Pump Industry Analyst
setting up an office and employing the right and enterprising people, we will make a difference. It will also ensure better communication between us and our customers, and it is important that we strengthen our network in this period when the financial crisis prevails worldwide,” added Mørkholt. For further information, visit www.desmi.com
Flowserve, Al-Rushaid open pump manufacturing facility in Saudi Arabia
F
lowserve Corp and Al-Rushaid Group have officially opened the largest pump manufacturing, repair and testing facility in the Middle East. The 11 500 sq m facility, based in Dhahran, Saudi Arabia, employs more than 100 people and is designed to support customers in the oil and gas, petrochemical, power, water, desalination, chemical and other industries. “We are very pleased to work with Flowserve to open this facility, which is designed to support major customers within Saudi Arabia and the surrounding Arabian Gulf Countries,” said Sheikh Abdullah Al-Rushaid, chairman, Al-Rushaid Group. “Together with Flowserve, we will help customers optimize plant uptime and develop ways to control their operating, maintenance and related costs.” “This state-of-the-art, robust facility helps us deliver outstanding service to our Middle East customers – its scope, size and capabilities are unmatched in the region,” said Lewis Kling, Flowserve president and CEO. “Flowserve is proud to partner with Al-Rushaid Group to bring technology and innovation to our customers in the critically important Arabian Gulf Region.” The facility is capable of certified testing to both API and international standards, for both horizontal and vertical pumps. Future expansion plans include the Middle East’s first hydraulics training centre, which will feature state-of-the-art classrooms, along with static and dynamic laboratories. For further information, visit www.flowserve.com and www.al-rushaid.com
Editorial Office: Elsevier Limited, The Boulevard, Langford Lane, Kidlington, Oxford OX5 1GB, United Kingdom Tel: +44 (0)1865 843695 Fax: +44 (0)1865 843933 Email: [email protected] Web: www.pumpindustryanalyst.com Editor: Roisin Reidy Production Editor: Lin Lucas Subscription Information An annual subscription to Pump Industry Analyst includes 12 printed issues and online access for up to 5 users. Prices: 1112 for all European countries & Iran US$1247 for all countries except Europe and Japan ¥147 800 for Japan (Prices valid until 31 December 2009) To subscribe send payment to the address above. Tel: +44 (0)1865 843687/Fax: +44 (0)1865 834971/ Email: [email protected], or via www.pumpindustryanalyst.com. Subscriptions run for 12 months, from the date payment is received. Periodicals postage is paid at Rahway, NJ 07065, USA. Postmaster send all USA address corrections to: Pump Industry Analyst, 365 Blair Road, Avenel, NJ 07001, USA Permissions may be sought directly from Elsevier Rights & Permissions Department, PO Box 800, Oxford OX5 1DX, UK; phone: (+44) 1865 843830, fax: (+44) 1865 853333, email: [email protected]. You may also contact Rights & Permissions directly through Elsevier’s home page (http://www. elsevier.com), selecting first ‘Customer Support’, then ‘General Information’, then Permissions Query Form’. In the USA, users may clear permissions and make payments through the Copyright Clearance Center, Inc., 222 Rosewood Drive, Danvers, MA 01923, USA; phone: (978) 7508400, fax: (978) 7504744, and in the UK through the Copyright Licensing Agency Rapid Clearance Service (CLARCS), 90 Tottenham Court Road, London W1P 0LP, UK; phone: (+44) 207 436 5931; fax: (+44) 207 436 3986. Other countries may have a local reprographic rights agency for payments. Derivative Works Subscribers may reproduce tables of contents or prepare lists of articles including abstracts for internal circulation within their institutions. Permission of the publisher is required for resale or distribution outside the institution. Permission of the publisher is required for all other derivative works, including compilations and translations. Electronic Storage or Usage Permission of the publisher is required to store or use electronically any material contained in this journal, including any article or part of an article. Contact the publisher at the address indicated. Except as outlined above, no part of this publication may be reproduced, stored in a retrieval system or transmitted in any form or by any means, electronic, mechanical, photocopying, recording or otherwise, without prior written permission of the publisher. Address permissions requests to: Elsevier Rights & Permissions Department, at the mail, fax and email addresses noted above. Notice No responsibility is assumed by the Publisher for any injury and/or damage to persons or property as a matter of products liability, negligence or otherwise, or from any use or operation of any methods, products, instructions or ideas contained in the material herein. Because of rapid advances in the medical sciences, in particular, independent verification of diagnoses and drug dosages should be made. Although all advertising material is expected to conform to ethical (medical) standards, inclusion in this publication does not constitute a guarantee or endorsement of the quality or value of such product or of the claims made of it by its manufacturer.
Printed by Mayfield Press (Oxford) LImited 02167
March 2009